Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023
August 02, 2023 16:00 ET
|
Genelux Corporation
WESTLAKE VILLAGE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO...